Blood Disorders
In a recent study, significantly more patients receiving the combination therapy met primary end point of reduction in spleen volume of ≥35 percent from baseline
pills medications
Adobe Stock
By:
Medically Reviewed By:
Farrokh Sohrabi, M.D.
Published on:
Updated on:
Mar 27, 2025, 3:41 pm
Loading content, please wait...
Journal
Prescription Drugs
Blood Cancer
Medication
Related Stories
No stories found.
© healthday-en 2025
Powered by Quintype